Cargando…

Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System

Lipid metabolism is altered in several cancer settings leading to different ratios of intermediates. Ovarian cancer is the most lethal gynecological malignancy. Cancer cells disperse in the abdominal space and ascites occurs. T cells obtained from ascites are unable to proliferate after an antigenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wefers, Christina, Duiveman-de Boer, Tjitske, Zusterzeel, Petra L. M., Massuger, Leon F. A. G., Fuchs, David, Torensma, Ruurd, Wheelock, Craig E., de Vries, I. Jolanda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796219/
https://www.ncbi.nlm.nih.gov/pubmed/29342108
http://dx.doi.org/10.3390/ijms19010273
_version_ 1783297461086846976
author Wefers, Christina
Duiveman-de Boer, Tjitske
Zusterzeel, Petra L. M.
Massuger, Leon F. A. G.
Fuchs, David
Torensma, Ruurd
Wheelock, Craig E.
de Vries, I. Jolanda M.
author_facet Wefers, Christina
Duiveman-de Boer, Tjitske
Zusterzeel, Petra L. M.
Massuger, Leon F. A. G.
Fuchs, David
Torensma, Ruurd
Wheelock, Craig E.
de Vries, I. Jolanda M.
author_sort Wefers, Christina
collection PubMed
description Lipid metabolism is altered in several cancer settings leading to different ratios of intermediates. Ovarian cancer is the most lethal gynecological malignancy. Cancer cells disperse in the abdominal space and ascites occurs. T cells obtained from ascites are unable to proliferate after an antigenic stimulus. The proliferation of ascites-derived T cells can be restored after culturing the cells for ten days in normal culture medium. No pathway aberrancies were detected. The acellular fraction of ascites can inhibit the proliferation of autologous as well as allogeneic peripheral blood lymphocytes, indicating the presence of soluble factors that interfere with T cell functionality. Therefore, we analyzed 109 lipid mediators and found differentially regulated lipids in suppressive ascitic fluid compared to normal abdominal fluid. Our study indicates the presence of lipid intermediates in ascites of ovarian cancer patients, which coincidences with T cell dysfunctionality. Since the immune system in the abdominal cavity is compromised, this may explain the high seeding efficiency of disseminated tumor cells. Further research is needed to fully understand the correlation between the various lipids and T cell proliferation, which could lead to new treatment options.
format Online
Article
Text
id pubmed-5796219
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57962192018-02-09 Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System Wefers, Christina Duiveman-de Boer, Tjitske Zusterzeel, Petra L. M. Massuger, Leon F. A. G. Fuchs, David Torensma, Ruurd Wheelock, Craig E. de Vries, I. Jolanda M. Int J Mol Sci Article Lipid metabolism is altered in several cancer settings leading to different ratios of intermediates. Ovarian cancer is the most lethal gynecological malignancy. Cancer cells disperse in the abdominal space and ascites occurs. T cells obtained from ascites are unable to proliferate after an antigenic stimulus. The proliferation of ascites-derived T cells can be restored after culturing the cells for ten days in normal culture medium. No pathway aberrancies were detected. The acellular fraction of ascites can inhibit the proliferation of autologous as well as allogeneic peripheral blood lymphocytes, indicating the presence of soluble factors that interfere with T cell functionality. Therefore, we analyzed 109 lipid mediators and found differentially regulated lipids in suppressive ascitic fluid compared to normal abdominal fluid. Our study indicates the presence of lipid intermediates in ascites of ovarian cancer patients, which coincidences with T cell dysfunctionality. Since the immune system in the abdominal cavity is compromised, this may explain the high seeding efficiency of disseminated tumor cells. Further research is needed to fully understand the correlation between the various lipids and T cell proliferation, which could lead to new treatment options. MDPI 2018-01-17 /pmc/articles/PMC5796219/ /pubmed/29342108 http://dx.doi.org/10.3390/ijms19010273 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wefers, Christina
Duiveman-de Boer, Tjitske
Zusterzeel, Petra L. M.
Massuger, Leon F. A. G.
Fuchs, David
Torensma, Ruurd
Wheelock, Craig E.
de Vries, I. Jolanda M.
Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System
title Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System
title_full Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System
title_fullStr Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System
title_full_unstemmed Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System
title_short Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System
title_sort different lipid regulation in ovarian cancer: inhibition of the immune system
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796219/
https://www.ncbi.nlm.nih.gov/pubmed/29342108
http://dx.doi.org/10.3390/ijms19010273
work_keys_str_mv AT weferschristina differentlipidregulationinovariancancerinhibitionoftheimmunesystem
AT duivemandeboertjitske differentlipidregulationinovariancancerinhibitionoftheimmunesystem
AT zusterzeelpetralm differentlipidregulationinovariancancerinhibitionoftheimmunesystem
AT massugerleonfag differentlipidregulationinovariancancerinhibitionoftheimmunesystem
AT fuchsdavid differentlipidregulationinovariancancerinhibitionoftheimmunesystem
AT torensmaruurd differentlipidregulationinovariancancerinhibitionoftheimmunesystem
AT wheelockcraige differentlipidregulationinovariancancerinhibitionoftheimmunesystem
AT devriesijolandam differentlipidregulationinovariancancerinhibitionoftheimmunesystem